On analyzing a large cohort of patients with PSP across different phenotypes, we found that the distribution patterns of 18F-Florzolotau accumulation observed in the living brains of patients with PSP are characterized by a remarkable similarity to the recently reconstructed maps of tau accumulation reported in post mortem research [2]. This evidence concerns the gene MAPT and supranuclear palsy, progressive, 1.